Archives

by in
Entry Author Date Location
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News 12/17/09 Seattle
From Russia With Love (for Biotech), Stewart Parker Gets “Antsy” to Return 12/14/09 Seattle
Oncothyreon Partner Starts New Lung Cancer Trial, Prompts Takeover Scuttle 12/10/09 Seattle
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News 11/19/09 Seattle
Oncothyreon Advances Cancer Drug 11/12/09 Seattle
Six Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney 10/15/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 09/22/09 Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News 08/13/09 Seattle
Oncothyreon Ends June with $22.7M 08/12/09 Seattle
Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News 08/11/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News 08/06/09 Seattle
Oncothyreon Raises $15M 08/04/09 Seattle
Oncothyreon Shows Long-Lasting Effect 08/03/09 Seattle
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News 06/25/09 Seattle
Oncothyreon Drug Enters Pivotal Trial 06/22/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results 06/01/09 Seattle
Calistoga Picks Up Buzz at ASCO, Thanks to Momentum from Rival 05/30/09 Seattle
Visible Raises $6M, Vulcan Goes Deep with BiPar, IdeaScale Serves White House, & More Seattle-Area Deals News 05/26/09 Seattle
Dendreon’s Manufacturing Challenge, Archus Cuts Deep, Accelerator Company Launches & More Seattle-Area Life Sciences News 05/21/09 Seattle
Oncothyreon Raises $11M 05/20/09 Seattle
Oncothyreon Cash Will Last 12 Months 05/14/09 Seattle
Dendreon’s “Clear Hit” on Provenge, Oncothyreon Rides Coattails, Cell Therapeutics Nabs $15M, & More Seattle-Area Life Sciences News 04/16/09 Seattle
Riding Dendreon’s Coattails, Antigenics and Oncothyreon Shares Soar 04/14/09 Seattle
Dendreon Saga Heads Toward Climax, As Cancer Drug Aims to Prove It Prolongs Lives 04/03/09 Seattle
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News 04/02/09 Seattle
Goodbye Cancer Vaccines, Hello Cancer Drugs: Oncothyreon Reinvents Itself 03/31/09 Seattle
The Northwest Biotech Survival Index 2: Companies Scraping By in Downturn 03/25/09 Seattle
Calistoga Reunites Icos Execs To Pursue Cancer, Inflammation Drugs 03/11/09 Seattle
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News 12/23/08 Seattle
Oncothyreon Sells Off Stimuvax, Cuts Jobs, Facilities To Preserve Cash 12/18/08 Seattle
Page 2 of 3 « previous page · next page »
    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.